G 209 (Moexipril 7.5 mg)
Pill imprint G 209 has been identified as Moexipril hydrochloride 7.5 mg.
Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- G 209
- Strength:
- 7.5 mg
- Color:
- Purple
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0209
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium oxide
magnesium stearate
povidone
hydroxypropyl cellulose (type h)
titanium dioxide
polyethylene glycol 6000
ferric oxide red
ferrosoferric oxide
hypromelloses
More about moexipril
Consumer resources
- Other brands: Univasc
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
